Open-label extension trial of the safety and tolerability of OROSO methylphenidate in adults with ADHD - the long-acting methylphenidate in adult ADHD (lamda) trial

被引：0
|
作者：
Kooij, S.
Medori, R.
Buitelaar, J.
Ramos-Quiroga, J. A.
Lee, E.
Casas, M.
机构：
来源：
JOURNAL OF NEURAL TRANSMISSION | 2007年 / 114卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：XCIII / XCIII
页数：1
相关论文
共 50 条
  • [21] An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations
    Childress, Ann C.
    Komolova, Marina
    Sallee, F. Randy
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (11) : 937 - 974
  • [22] Heterogeneity in ADHD children's response to two long-acting methylphenidate formulations
    Sonuge-Barke, E. J. S.
    Swanson, J.
    Hatch, S.
    Van Lier, P.
    Vandenberghe, M.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (07) : LXXXIX - LXXXIX
  • [23] Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trial
    Purper-Ouakil, Diane
    Blasco-Fontecilla, Hilario
    Ros, Tomas
    Acquaviva, Eric
    Banaschewski, Tobias
    Baumeister, Sarah
    Bousquet, Elisa
    Bussalb, Aurore
    Delhaye, Marie
    Delorme, Richard
    Drechsler, Renate
    Goujon, Allison
    Hage, Alexander
    Kaiser, Anna
    Mayaud, Louis
    Mechler, Konstantin
    Menache, Caroline
    Revol, Olivier
    Tagwerker, Friederike
    Walitza, Susanne
    Werling, Anna Maria
    Bioulac, Stephanie
    Brandeis, Daniel
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2022, 63 (02) : 187 - 198
  • [24] A Prospective Open-label Trial of Long-Acting Liquid Methylphenidate for the Treatment of Attention Deficit/Hyperactivity Disorder in Intellectually Capable Adults with Autism Spectrum Disorder
    Joshi, Gagan
    DiSalvo, Maura
    Ceranoglu, T. Atilla
    Wozniak, Janet
    Galdo, Maribel
    Hoskova, Barbora
    Dallenbach, Nina
    Castle, Rose
    Biederman, Joseph
    NEUROLOGY, 2019, 92 (15)
  • [25] Methylphenidate Transdermal System in Adults With Past Stimulant Misuse: An Open-Label Trial
    McRae-Clark, Aimee L.
    Brady, Kathleen T.
    Hartwell, Karen J.
    White, Kathleen
    Carter, Rickey E.
    JOURNAL OF ATTENTION DISORDERS, 2011, 15 (07) : 539 - 544
  • [26] Efficacy and Safety of PRC-063, Extended-Release Multilayer Methylphenidate in Adults with ADHD Including 6-Month Open-Label Extension
    Weiss, Margaret D.
    Childress, Ann C.
    Donnelly, Graeme A. E.
    JOURNAL OF ATTENTION DISORDERS, 2021, 25 (10) : 1417 - 1428
  • [27] Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD
    Bioulac, Stephanie
    Purper-Ouakil, Diane
    Ross, Tomas
    Blasco-Fontecilla, Hilario
    Prats, Marie
    Mayaud, Louis
    Brandeis, Daniel
    BMC PSYCHIATRY, 2019, 19 (1)
  • [28] Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD
    Stéphanie Bioulac
    Diane Purper-Ouakil
    Tomas Ros
    Hilario Blasco-Fontecilla
    Marie Prats
    Louis Mayaud
    Daniel Brandeis
    BMC Psychiatry, 19
  • [29] Added benefits of long-term treatment of methylphenidate modified-release long-acting formulation in adults with ADHD
    Huss, M.
    Ginsberg, Y.
    Arngrim, T.
    Philipsen, A.
    Gandhi, P.
    Chen, C. W.
    Kumar, V.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S210 - S210
  • [30] OROS methylphenidate in the treatment of adults with ADHD: A 6-month, open-label, follow-up study
    Marchant, Barrie K.
    Reimherr, Frederick W.
    Halls, Corinne
    Williams, Erika D.
    Strong, Robert E.
    ANNALS OF CLINICAL PSYCHIATRY, 2010, 22 (03) : 196 - 204
12345